# OMNISEQ, INC.: Form D filings

OMNISEQ, INC., a biotechnology company in Buffalo, NY, filed 3 Form D notices with the SEC between 2017 and 2019. The latest, on June 21, 2019, reports $1.6 million sold of a $1.6 million offering to 4 investors.

Find out what OMNISEQ, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20OMNISEQ%2C%20INC.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=OMNISEQ%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fomniseq-inc-1713983)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20OMNISEQ%2C%20INC.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=OMNISEQ%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fomniseq-inc-1713983)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New York](https://specstream.ai/data/form-d/state/new-york): 4,357 rows, by operating companies, filed since November 1, 2024, $123.57, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-york
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 700 ELLICOTT STREET, Buffalo, NY, 14203
- Phone: (800) 781-1259
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2015
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(c)
- SEC identifier (CIK): 1713983

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jun 21, 2019 | New notice | $1,568,650 | $1,568,650 | $0 | 4 | Jun 21, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1713983/000171398319000002/0001713983-19-000002-index.htm) |
| May 3, 2019 | New notice | $7,325,000 | $7,325,000 | $0 | 1 | Apr 18, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1713983/000171398319000001/0001713983-19-000001-index.htm) |
| Aug 18, 2017 | New notice | $20,000,000 | $10,000,000 | $10,000,000 | 2 | Aug 4, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1713983/000171398317000001/0001713983-17-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Carl Morrison | Director |  |
| Mark Gardner | Director |  |
| Paul Buford Billings | Director |  |
| Margot Schoenborn | Executive Officer, Director |  |
| R. Buford Sears | Director |  |
| Marcia Buford Eisenberg | Director |  |
| Kenneth Buford Manning | Director |  |
| Steven Buford Anderson | Director |  |

## Other biotechnology companies in New York that filed recently

- [Swep Bio, Inc.](https://specstream.ai/data/form-d/company/swep-bio-inc-2159106) $2.5 million · Oct 29, 2026
- [Hypercell Technologies Inc.](https://specstream.ai/data/form-d/company/hypercell-technologies-inc-1882357) $3 million · Oct 14, 2026
- [CAD Therapeutics, Inc.](https://specstream.ai/data/form-d/company/cad-therapeutics-inc-2157566) $4 million · Oct 2, 2026
- [Vicora, Inc.](https://specstream.ai/data/form-d/company/vicora-inc-2091847) $2.3 million · Sep 18, 2026
- [GevRx Nutraceuticals, Inc.](https://specstream.ai/data/form-d/company/gevrx-nutraceuticals-inc-2156105) $300,000 · Sep 18, 2026
- [Episteme Prognostics, Inc.](https://specstream.ai/data/form-d/company/episteme-prognostics-inc-1902402) $5.1 million · Sep 4, 2026

[Every Form D from the week of Jun 17, 2019](https://specstream.ai/data/form-d/week/2019-06-17) · [All recent filings in New York](https://specstream.ai/data/form-d/state/new-york) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what OMNISEQ, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).